Searched for
ROCHE HOLDING
European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...- Global funds, same tech bet? The diversification trap Indian investors may missMany Indian investors mistakenly believe they diversify their portfolios by adding foreign countries. However, numerous global indices ofte...
- Could AI chip boom make ASML Europe's first trillion-dollar firm?After blowout second quarter earnings, investors and analysts are asking a once far-fetched question: could ASML become Europe's first ever...
- Warburg, Bain, CVC among PE firms in talks to buy into Agappe DiagnosticsSeveral global private equity firms are exploring a significant stake purchase in Agappe Diagnostics. This potential deal involves both exi...
- AI Euphoria, Fed Signals and Oil Politics: David Roche warns markets may be ignoring bigger risksGlobal markets are optimistic about AI and easing inflation, but David Roche warns of deeper structural risks. He believes the AI investmen...
- Roche Pharma India to appoint Rajwinder Mehdwan as country general managerRoche Pharma India has announced that Rajwinder Mehdwan will take over as the country general manager from April 1, 2025, replacing V Simps...
- European shares rise as US data soothes economic slowdown fearsInvestors are keenly watching a panel discussion of central bankers in Sintra, including European Central Bank President Christine Lagarde,...
- At last, a drug to slow down Alzheimer'sEisai Co, a Tokyo-based pharmaceutical company with a family bent and market capitalisation of $14 billion, crossed the finish line before ...
- Court defers decision on Roche's plea against Zydus' cancer drugRoche sued Zydus Cadila and the DCGI last week, alleging that the Indian company launched its product, Vivitra, in the country without gene...
- Swiss voters reject strictest executive pay limitsSwiss voters rejected a proposal to limit executives’ pay to 12 times that of junior employees on Sunday.
- IPAB revokes two Allergan patents on Ajanta Pharma challengeDrug firm Ajanta Pharma today said it has been successful in its challenge to revoke patents held by Allergan Inc for two drugs used for ey...
- Roche lost Indian patent as it didn't comply local norms:GovernmentRoche lost an Indian patent for breast cancer drug 'Herceptin' as it did not comply with local norms after facing a post grant challenge, g...
- Cipla wins cancer drug patent caseCipla says it has scored a "landmark" court win in a patent challenge launched by Switzerland's Roche Holding over its version of a lung-ca...
- Roche Holding AG makes $5.7 bn offer for Illumina IncA takeover of Illumina would be Roche’s largest purchase since the $46.8 billion acquisition of Genentech Inc., completed in March 2009.
- Cipla to partner Chinese co in selling Roche, Amgen drug clonesCipla, the Indian drugmaker that built a $1-billion business making generic HIV treatments, aims to sell copies of Roche Holding's and Amge...
- Roche says half-year profit down 29 per centPharmaceuticals maker Roche Holding AG says net income was down 29 per cent for the first half after the takeover of Genentech.
- Roche seals $47-b Genentech dealSwiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44% of biotech pioneer Genentech that it doesn’t already own, endin...
- Roche makes 'cheaper' bid for GenentechRoche Holding AG lowered the acquisition price by 2.8% and took the offer for the US cancer-drug developer directly to shareholders.
- Roche to force through Ventana mergerPharmaceuticals maker Roche Holding AG said on Tuesday it is poised to complete its acquisition of Ventana Medical Systems Inc.
- EU regulator recalls Roche’s anti-HIV drug on contamination fearsEurope’s drug regulating body on Wednesday recalled an HIV treatment made by Roche Holding because of contamination.
Load More
